TNFSF11
Tumor necrosis factor ligand superfamily member 11
Also known as: CD254, ODF, OPGL, RANKL, TNF11_HUMAN, TRANCE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14788
- Gene
- TNFSF11
- Ensembl
- ENSG00000120659
- Chromosome
- 13
- Canonical length
- 317 aa
- Protein class
- Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
317 residues, UniProt reviewed canonical sequence.
>O14788|TNFSF11
1 MRRASRDYTK YLRGSEEMGG GPGAPHEGPL HAPPPPAPHQ PPAASRSMFV ALLGLGLGQV
61 VCSVALFFYF RAQMDPNRIS EDGTHCIYRI LRLHENADFQ DTTLESQDTK LIPDSCRRIK
121 QAFQGAVQKE LQHIVGSQHI RAEKAMVDGS WLDLAKRSKL EAQPFAHLTI NATDIPSGSH
181 KVSLSSWYHD RGWAKISNMT FSNGKLIVNQ DGFYYLYANI CFRHHETSGD LATEYLQLMV
241 YVTKTSIKIP SSHTLMKGGS TKYWSGNSEF HFYSINVGGF FKLRSGEEIS IEVSNPSLLD
301 PDQDATYFGA FKVRDIDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFSF11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 12 nTPM
- appendix: 4.3 nTPM
- liver: 3.9 nTPM
- tonsil: 3.5 nTPM
- breast: 2.6 nTPM
- rectum: 1.6 nTPM
Single-cell type
- innate lymphoid cells: 147 nCPM
- late spermatids: 35 nCPM
- thymic myoid cells: 33 nCPM
- breast hormone-responsive cells: 28 nCPM
- early spermatids: 11 nCPM
- respiratory ionocytes: 10 nCPM
Immune cell
- NK-cell: 9.9 nTPM
- basophil: 1.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- medulla oblongata: 1 nTPM
- choroid plexus: 0.6 nTPM
- hypothalamus: 0.4 nTPM
- midbrain: 0.3 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNFSF11.
Disease | AllUniProt
Conditions TNFSF11 is implicated in, by any mechanism.
- Osteopetrosis, autosomal recessive 2 (OPTB2) MIM:259710
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 264 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive osteopetrosis 2
Disease | ImmuneIEDB
Conditions an epitope on TNFSF11 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.93
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone resorption
- calcium ion homeostasis
- calcium-mediated signaling
- cell surface receptor signaling pathway
- cellular response to leukemia inhibitory factor
- cytokine-mediated signaling pathway
- immune response
- JNK cascade
- mammary gland alveolus development
- mammary gland epithelial cell proliferation
- monocyte chemotaxis
- negative regulation of transcription by RNA polymerase II
- ossification
- osteoclast development
- osteoclast differentiation
- osteoclast proliferation
- paracrine signaling
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of bone resorption
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of corticotropin-releasing hormone secretion
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of extrinsic apoptotic signaling pathway
- positive regulation of fever generation by positive regulation of prostaglandin secretion
- positive regulation of gene expression
- positive regulation of homotypic cell-cell adhesion
- positive regulation of intracellular signal transduction
- positive regulation of JNK cascade
- positive regulation of MAPK cascade
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of osteoclast development
- positive regulation of osteoclast differentiation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of T cell activation
- positive regulation of transcription by RNA polymerase II
- tooth eruption
- tumor necrosis factor-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFSF11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFSF11 as an antibody target. Whether an autoantibody or antibody against TNFSF11 could matter depends on whether native TNFSF11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFSF11 is annotated at the cell surface, where native TNFSF11 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFSF11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...